期刊
PEDIATRICS
卷 129, 期 1, 页码 E148-E156出版社
AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2011-0544
关键词
diaphragmatic paralysis; distal muscular weakness; natural disease course; neuromuscular disease; SMARD1
类别
资金
- Deutsche Forschungsgemeinschaft [HU 408/3-2,-3]
- Charite
- European Society for Paediatric Endocrinology (ESPE)
- Deutsche Forschungsgemeinschaft via the Neuro-Cure Cluster of Excellence [Exc 257]
- MRC [G1001964] Funding Source: UKRI
- Medical Research Council [G1001964] Funding Source: researchfish
BACKGROUND: Only scarce information is available on the long-term outcome and the natural course of children with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1) due to mutations in the IGHMBP2 gene. OBJECTIVE: To describe the natural disease course, to systematically quantify the residual capacities of children with SMARD1 who survive on permanent mechanical respiration, and to identify markers predicting the disease outcome at the time of manifestation. METHODS: We conducted a longitudinal study of 11 infantile SMARD1 patients over a mean observational period of 7.8 (SD 3.2) years. Disease-specific features were continuously assessed by using a semiquantitative scoring system. Additionally, we analyzed the residual enzymatic activity of 6 IGHMBP2 mutants in our patients. RESULTS: After an initial rapid decline of the clinical score until the age of 2 years, residual capabilities reached a plateau or even improved. The overall clinical outcome was markedly heterogeneous, but clinical scores at the age of 3 months showed a positive linear correlation with the clinical outcome at 1 year and at 4 years of age. If expressed in an in vitro recombinant system, mutations of patients with more favorable outcomes retained residual enzymatic activity. CONCLUSIONS: Despite their severe disabilities and symptoms, most SMARD1 patients are well integrated into their home environment and two thirds of them are able to attend kindergarten or school. This information will help to counsel parents at the time of disease manifestation. Pediatrics 2012; 129: e148-e156
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据